Login / Signup

Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex.

Chloé LoiseauDaniela BritesIrmgard MoserFrancesc CollChristine PourcelSuelee Robbe-AustermanVincent EscuyerKimberlee A MusserSharon J PeacockSilke FeuerriegelThomas A KohlStefan NiemannSebastien GagneuxClaudio Umberto Köser
Published in: Antimicrobial agents and chemotherapy (2019)
Using 894 phylogenetically diverse genomes of the Mycobacterium tuberculosis complex (MTBC), we simulated in silico the ability of the Hain Lifescience GenoType MTBC assay to differentiate the causative agents of tuberculosis. Here, we propose a revised interpretation of this assay to reflect its strengths (e.g., it can distinguish some strains of Mycobacterium canettii and variants of Mycobacterium bovis that are not intrinsically resistant to pyrazinamide) and limitations (e.g., Mycobacterium orygis cannot be differentiated from Mycobacterium africanum).
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • escherichia coli
  • emergency department
  • molecular docking
  • human immunodeficiency virus